CELLiST™ Media Switch Program is a strategic approach of media change for biopharmaceuticals from development stage to clinical phase. This program allows’ for efficient biopharmaceutical development using high-quality CELLiST™ Media with a reasonable price.
The Company processes personal information for the following purposes. The personal information being processed will not be used for purposes other than the following purposes, and if there is a change to the purpose of use, prior consent will be asked for.
Users can exercise the following rights as the subject of personal information.
In accordance with Article 29 of the Personal Information Protection Act, the Company takes technical, administrative, and physical measures necessary to ensure safety as follows:
※The organizations listed below are independent agencies not affiliated with the Company; if you are not satisfied with the handling of the complaint about personal information by the Company or the damage relief results, or if you need more specific help, please contact the following organizations.▶Personal Information Infringement Report Center (operated by Korea Internet & Security Agency)